Header cover image

Investing Ideas
/
Swedish Pharmaceuticals & Biotech High Insider Buying

Swedish Pharmaceuticals & Biotech High Insider Buying

Results

19

4 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

19 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	BIOA B BioArctic	SEK 178.10	17.6%	-24.5%	SEK 15.7b	SEK 320.80	PS94.3x	E62.2%	0%
	ALIF B AddLife	SEK 128.30	-4.9%	39.5%	SEK 15.6b	SEK 165.50	PE133.6x	E52.0%	0.4%
	MCAP MedCap	SEK 520.00	-3.9%	69.1%	SEK 7.7b	SEK 535.00	PE33.8x	S13.2%	n/a
	SECARE Swedencare	SEK 44.94	-0.5%	-23.0%	SEK 7.1b	SEK 58.67	PE115x	E64.2%	0.5%
	EGTX Egetis Therapeutics	SEK 5.43	4.8%	2.5%	SEK 2.0b	SEK 10.80	PS28.7x	E106.4%	n/a
	GENO Genovis AB (publ.)	SEK 27.60	4.2%	-40.5%	SEK 1.8b	SEK 39.00	PE64.7x	E16.4%	n/a
	ISOFOL Isofol Medical	SEK 3.32	15.9%	319.2%	SEK 536.2m	SEK 0.77	PB5.9x	n/a	n/a
	IBT B Infant Bacterial Therapeutics	SEK 37.30	8.7%	-58.7%	SEK 502.5m	n/a	PS100496.8x	n/a	n/a
	DICOT Dicot Pharma	SEK 0.23	-9.4%	54.3%	SEK 411.8m	n/a	PB32.9x	n/a	n/a
	ENZY Enzymatica	SEK 1.86	1.6%	-45.3%	SEK 401.3m	SEK 4.00	PS9.1x	E67.8%	n/a
	ACE New Ascelia Pharma	SEK 2.67	2.9%	-7.1%	SEK 252.2m	SEK 8.25	PB2.4x	E47.2%	n/a
	ERMA Enorama Pharma	SEK 4.09	2.5%	38.2%	SEK 247.3m	n/a	PS42.1x	n/a	n/a
	BIOVIC B New Biovica International	SEK 1.80	3.3%	-35.6%	SEK 162.8m	SEK 6.20	PS22.5x	E78.5%	n/a
	KAN New Kancera	SEK 1.08	29.0%	-68.4%	SEK 130.9m	SEK 3.10	PB1.6x	E47.8%	n/a
	PILA New Pila Pharma	SEK 4.41	5.8%	198.0%	SEK 119.6m	n/a	PS114x	n/a	n/a
	TOL Toleranzia	SEK 0.57	11.8%	34.9%	SEK 111.9m	n/a	PS3.2x	n/a	n/a
	LPGO Lipigon Pharmaceuticals	SEK 0.13	-2.7%	-67.4%	SEK 19.2m	SEK 1.60	PS2.1x	E116.3%	n/a
	ZICC Ziccum	SEK 1.01	-51.7%	-84.5%	SEK 16.0m	n/a	PS2.8x	n/a	n/a
	PHAL PharmaLundensis	SEK 0.36	0%	-44.6%	SEK 15.3m	n/a	PB4.8x	n/a	n/a

Page 1 of 1